A clinical trial to induce immunity and herd immunity against viruses including covid 19
Phase 2
- Registration Number
- CTRI/2021/02/031547
- Lead Sponsor
- Dr Hashmis Unani Medcine Observation Research Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
age group 9 to 80 years male and female with normal vitals and blood sugar
Exclusion Criteria
below 9 years, between mensuration in females and pregnancy in females
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method stress levels willbe reduced, frequency of cold effects will be reduced, tummy troubles (constipation and indigestion issues) will be reduced and feeling of triedness will be reducedTimepoint: 0 to 8 weeks
- Secondary Outcome Measures
Name Time Method stress levels willbe reduced, frequency of cold effects will be reduced, tummy troubles (constipation and indigestion issues) will be reduced and feeling of triedness will be reducedTimepoint: 0 to 8 weeks